Friday November 27 2009 | Biotechnology feed | All feeds
|
|
|
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus ErythematosusMonday 20th of July 2009 0:01BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:
 Related Web-Links(If any, Generated Automatically)
Source PR Newswire  |
|
Nothing in this website should be used in
place of personal medical advice from your own qualified medical
practitioner. |
All rights reserved. All other trademarks recognized. |
|
